RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial (Fertility and Sterility (2009) 92(3) (849–852), (S0015028207005328), (10.1016/j.fertnstert.2007.02.062));Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial

Fertility and Sterility

Volumn 92, Issue 3, 2009, Pages 849-852

  Badawy, Ahmed ^a   Abdel Aal, Ibrahim ^a   Abulatta, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

clomiphene citrate; Letrozole; PCOS

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; LETROZOLE; PROGESTERONE;

ADULT; ANOVULATION; ARTICLE; CLINICAL TRIAL; DRUG CHOICE; EGYPT; EMBRYOTOXICITY; ENDOMETRIUM; EYE TOXICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PARITY; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; TERATOGENICITY; UNIVERSITY HOSPITAL;

EID: 69049088768     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2020.08.1408     Document Type: Erratum

References (24)

1. Kovacs G., and Wood C. The current status of polycystic ovary syndrome. Aust NZ J Obstet Gynecol 41 (2001) 65-68
2. Guzick D. Polycystic ovary syndrome. Symptomatology, pathophysiology and epidemiology. Am J Obstet Gynecol 179 (1998) 89-93
3. Slowey M.J. Polycystic ovary syndrome: new perspective on an old problem. South Med J 94 (2001) 190-195
4. Franks S., Adams J., Mason H., and Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynecol 12 (1985) 605-632
5. Kistner R.W. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Survey 20 (1965) 873-900
6. Pfister C.U., Martoni A., Zamagni C., Lelli G., De Braud F., and Souppart C. Effect of age and single versus multiple doses, pharmacokinetic of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos 22 (2001) 191-197
7. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
8. Gonen Y., and Casper R.F. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5 (1990) 670-674
9. Yagel S., Ben-Chetrit A., Anteby E., Zacut D., Hochner-Celnikier D., and Ron M. The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil Steril 57 (1992) 33-36
10. Dickey R.P., Olar T.T., Taylor S.N., Curole D.N., and Matulich E.M. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 59 (1993) 756-760
11. Opsahl M.S., Robins E.D., O'Connor D.M., Scott R.T., and Fritz M.A. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 66 (1996) 533-539
12. Eden J.A., Place J., Carter G.D., Jones J., Alaghband-Zadeh J., and Pawson M.E. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol 73 (1989) 187-190
13. Mitwally M., and Casper R. Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 (2001) 305-309
14. Bayar U., Tanri{dotless}verdi H.A., Aykut B., Ayoglu F., Özcan O., and Erdal K. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril 85 (2006) 1045-1048
15. Al-Fozan H., Al-Khadouri M., Tang S.L., and Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 82 (2004) 1561-1563
16. Mitwally M., and Casper R. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 77 (2002) 776-780
17. Healey S., Tan S.L., Tulandi T., and Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 80 (2003) 1325-1329
18. Jee B.C., Ku S.Y., Suh C.S., Kim K.C., Lee W.D., and Kim S.H. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril 85 (2006) 1774-1777
19. Cortinez I., De Carvalho D., Vantman F., Gabler G., Iniguez R., and Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 83 (2005) 110-115
20. Fisher S.A., Reid R.L., Van Vugt D.A., and Casper R.F. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 78 (2002) 280-285
21. Kilic-Okman T., Kucuk M., and Altaner S. Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat. Fertil Steril 80 (2003) 1330-1332
22. Bishai R., Arbour L., Lyons C., and Koren G. Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology 60 (1999) 143-145
23. Mitwally M., Biljan M., and Casper R. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 192 (2005) 381-386
24. Bedaiwy M., Forman R., Mousa N., Al Inany H., and Casper R. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Human Reprod 21 (2006) 2838-2844